Solvay (company)

From Wikipedia, the free encyclopedia

To meet Wikipedia's quality standards and comply with Wikipedia's neutral point of view policy, this article or section may require cleanup.
This article or section reads like an advertisement.
Please discuss this issue on the talk page. Editing help is available.
Blatant advertising can be marked for speedy deletion with {{db-spam}}.

Solvay SA <tr><td colspan="2" style="text-align:center; padding:16px 0 16px 0;">Image:Solvaylogo.jpg</td></tr>
Type	Public
Founded	1863
Headquarters	Brussels, Belgium <tr><th style="text-align:right; padding-right:0.75em;">Key people</th><td>Aloïs Michielsen (Chairman of the board), Christian Jourquin (Chairman of the Executive Committee)</td></tr><tr><th style="text-align:right; padding-right:0.75em;">Industry</th><td>Chemicals</td></tr><tr><th style="text-align:right; padding-right:0.75em;">Products</th><td>Pharmaceuticals, chemicals and plastics</td></tr><tr><th style="text-align:right; padding-right:0.75em;">Revenue</th><td>€8.562 billion (2005)</td></tr><tr><th style="text-align:right; padding-right:0.75em;">Employees</th><td>28,730</td></tr><tr><th style="text-align:right; padding-right:0.75em;">Website</th><td>http://www.solvay.com/</td></tr>

This article deals with the company named Solvay. For other meanings see Solvay.

Solvay is an international chemical and pharmaceutical company. It was founded in 1863 by Ernest Solvay to produce sodium carbonate by the solvay process. Since then it has diversified to three major sectors of activity: Pharmaceuticals, Chemicals and Plastics.

Solvay, which operates in Pharmaceuticals, Chemicals and Plastics, generated EUR 8.6 billion of sales in 2005 from more than 400 units in over 50 countries. Almost 30,000 people, 2,650 of them in research, apply their talents daily to satisfying the Group’s 160,000 clients.

[edit] Pharmaceuticals

Solvay Pharmaceuticals activities of the human health group are focused on four main areas: psychiatry, gastroenterology, gynaecology and cardiology.

Solvay is a research based company and invests 17% of its annual sales, more than the industrial average, into research and development of innovative products.

R & D Centres are located in Hannover (Germany), Paris (France), Weesp (The Netherlands), Marietta, GA (USA) and Tokyo (Japan) with over 1,100 people working in this area.

Solvay reputation for innovative products has already made its mark in pyschiatry with the development of fluvoxamine (Luvox, Fevarin, Dumirox), the world's first selective serotonin reuptake inhibitor (SSRI). Flesinoxan for the treatment of depression and anxiety is in development.

With the development of the new antihypertensive moxonidine (Physiotens, Normotens, Moxol), an imidazoline type 1 receptor antagonist, Solvay has introduced an innovative therapeutic approach in cardiology.

[edit] External links

Company website

This chemical corporation-related article is a stub. You can help Wikipedia by expanding it.

BEL20 companies of Belgium
Agfa-Gevaert \| Barco \| Bekaert \| Belgacom \| Cofinimmo \| Colruyt \| Delhaize Group \| Dexia \| Fortis \| GBL \| InBev \| KBC Groep \| Mobistar \| NPM/CNP \| Omega Pharma \| Solvay \| Suez \| UCB \| Umicore